Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Waste Management (New York, N.Y.)|May 14, 2017
Pilot trial on separation conditions for diaper recyclingKyung-Shin Kim, Hee-Sun Cho
International Journal of Molecular Sciences|March 28, 2026
Liver Transplantation Following Immune Checkpoint Inhibitor Therapy: What Do We Need to Know from Clinical and Immunological Perspective?Hee Sun Cho, Soon Kyu Lee
Medicine|April 1, 2022
Case report: atrial septostomy as a bridge to lung transplantation in a patient with venovenous extracorporeal membrane oxygenationJiwon Ryoo, Jung Huh, Hee Sun Cho, et al.
Cancers|December 30, 2025
Prognostic Significance of Glypican-3 Expression in Hepatocellular Carcinoma Treated with Atezolizumab-BevacizumabJi Hoon Kim, Ji Won Han, Hee Sun Cho, et al.
Journal of Liver Cancer|December 4, 2025
PNPLA3 I148M is unrelated to HCC occurrence but associates with poorer tumor differentiation in Korean MASLD: a prospective cohort of 562 patientsJaejun Lee, Dong Yeop Lee, Jung Hoon Cha, et al.
Biomedicines|February 27, 2026
Shelterin Component TPP1 Drives Tumor Progression and Predicts Poor Prognosis in Hepatocellular CarcinomaJung Eun Jang, Hye Seon Kim, Jin Seoub Kim, et al.
Frontiers in Immunology|June 26, 2025
Peripheral blood inflammatory score using a cytokine multiplex assay predicts clinical outcomes in patients treated with atezolizumab-bevacizumab for unresectable HCCHee Sun Cho, Soon Kyu Lee, Ji Won Han, et al.
Hepatology International|December 9, 2025
Expanded but dysfunctional regulatory T cells in treatment-naïve autoimmune hepatitisMi Hyun Kwon, Eun Ji Jang, Kwon Yong Tak, et al.
Abdominal Radiology (New York)|April 28, 2024
Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective studyJae-Sung Yoo, Ji Hoon Kim, Hee Sun Cho, et al.
World Journal of Gastrointestinal Surgery|January 15, 2024
Association between the early high level of serum tacrolimus and recurrence of hepatocellular carcinoma in ABO-incompatible liver transplantationJi Won Han, Jong Young Choi, Eun Sun Jung, et al.
Pageof 2